tailieunhanh - Báo cáo khoa học: "Radiotherapy quality assurance review in a multi-center randomized trial of limited-disease small cell lung cancer: the Japan Clinical Oncology Group (JCOG) trial 0202"

Tuyển tập các báo cáo nghiên cứu về y học được đăng trên tạp chí y học Radiation Oncology cung cấp cho các bạn kiến thức về ngành y đề tài: "Radiotherapy quality assurance review in a multi-center randomized trial of limited-disease small cell lung cancer: the Japan Clinical Oncology Group (JCOG) trial 0202. | Radiation Oncology BioMed Central Open Access Radiotherapy quality assurance review in a multi-center randomized trial of limited-disease small cell lung cancer the Japan Clinical Oncology Group JCOG trial 0202 Naoko Sanuki-Fujimotot1 Satoshi Ishikura 2 Kazushige Hayakawa2 Kaoru Kubota3 Yutaka Nishiwaki3 and Tomohide Tamura3 Address 1Clinical Trials and Practice Support Division Center for Cancer Control and Information Services National Cancer Center 5-1-1 Tsukiji Chuo-ku Tokyo 104-0045 Japan 2JCOG radiotherapy committee Clinical Trials and Practice Support Division Center for Cancer Control and Information Services National Cancer Center 5-1-1 Tsukiji Chuo-ku Tokyo 104-0045 Japan and 3JCOG lung cancer study group Thoracic Oncology Division National Cancer Center Hospital 5-1-1 Tsukiji Chuo-ku Tokyo 104-0045 Japan Email Naoko Sanuki-Fujimoto - nao5-tky@ Satoshi Ishikura - sishikur@ Kazushige Hayakawa - hayakazu@ Kaoru Kubota - kkubota@ Yutaka Nishiwaki - ynishiwa@ Tomohide Tamura - ttamura@ Corresponding author fEqual contributors Published 2 June 2009 Received 20 February 2009 Radiation Oncology 2009 4 16 doi 174 -717X-4-16 Accepted 2 June 2009 This article is available from http content 4 1 16 2009 Sanuki-Fujimoto et al licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License http licenses by which permits unrestricted use distribution and reproduction in any medium provided the original work is properly cited. Abstract Background The purpose of this study was to analyze the radiotherapy RT quality assurance QA assessment in Japan Clinical Oncology Group JCOG 0202 which was the first trial that required on-going RT QA review in the JCOG. Methods JCOG 0202 was a multi-center phase III trial comparing two types of consolidation chemotherapy after concurrent .